Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles produced from cholesterol and phospholipids. Recently, liposomes have been widely administered intranasally for systemic and brain delivery. From the nasal cavity, liposome-encapsulated drugs and genes enter the system...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/15/1/207 |
| _version_ | 1797437813158838272 |
|---|---|
| author | Van-An Duong Thi-Thao-Linh Nguyen Han-Joo Maeng |
| author_facet | Van-An Duong Thi-Thao-Linh Nguyen Han-Joo Maeng |
| author_sort | Van-An Duong |
| collection | DOAJ |
| description | Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles produced from cholesterol and phospholipids. Recently, liposomes have been widely administered intranasally for systemic and brain delivery. From the nasal cavity, liposome-encapsulated drugs and genes enter the systemic circulation primarily via absorption in the respiratory region, whereas they can be directly transported to the brain via the olfactory pathway. Liposomes can protect drugs and genes from enzymatic degradation, increase drug absorption across the nasal epithelium, and prolong the residence time in the nasal cavity. Intranasal liposomes are also a potential approach for vaccine delivery. Liposomes can be used as a platform to load antigens and as vaccine adjuvants to induce a robust immune response. With the recent interest in intranasal liposome formulations, this review discusses various aspects of liposomes that make them suitable for intranasal administration. We have summarized the latest advancements and applications of liposomes and evaluated their performance in the systemic and brain delivery of drugs and genes administered intranasally. We have also reviewed recent advances in intranasal liposome vaccine development and proposed perspectives on the future of intranasal liposomes. |
| first_indexed | 2024-03-09T11:28:03Z |
| format | Article |
| id | doaj.art-ee122506bb934244a3d2741b7bfabba2 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-09T11:28:03Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-ee122506bb934244a3d2741b7bfabba22023-11-30T23:59:11ZengMDPI AGPharmaceutics1999-49232023-01-0115120710.3390/pharmaceutics15010207Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine DeliveryVan-An Duong0Thi-Thao-Linh Nguyen1Han-Joo Maeng2College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of KoreaCollege of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of KoreaCollege of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of KoreaLiposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles produced from cholesterol and phospholipids. Recently, liposomes have been widely administered intranasally for systemic and brain delivery. From the nasal cavity, liposome-encapsulated drugs and genes enter the systemic circulation primarily via absorption in the respiratory region, whereas they can be directly transported to the brain via the olfactory pathway. Liposomes can protect drugs and genes from enzymatic degradation, increase drug absorption across the nasal epithelium, and prolong the residence time in the nasal cavity. Intranasal liposomes are also a potential approach for vaccine delivery. Liposomes can be used as a platform to load antigens and as vaccine adjuvants to induce a robust immune response. With the recent interest in intranasal liposome formulations, this review discusses various aspects of liposomes that make them suitable for intranasal administration. We have summarized the latest advancements and applications of liposomes and evaluated their performance in the systemic and brain delivery of drugs and genes administered intranasally. We have also reviewed recent advances in intranasal liposome vaccine development and proposed perspectives on the future of intranasal liposomes.https://www.mdpi.com/1999-4923/15/1/207liposomeintranasalsystemicbrainphospholipidbioavailability |
| spellingShingle | Van-An Duong Thi-Thao-Linh Nguyen Han-Joo Maeng Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery Pharmaceutics liposome intranasal systemic brain phospholipid bioavailability |
| title | Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery |
| title_full | Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery |
| title_fullStr | Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery |
| title_full_unstemmed | Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery |
| title_short | Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery |
| title_sort | recent advances in intranasal liposomes for drug gene and vaccine delivery |
| topic | liposome intranasal systemic brain phospholipid bioavailability |
| url | https://www.mdpi.com/1999-4923/15/1/207 |
| work_keys_str_mv | AT vananduong recentadvancesinintranasalliposomesfordruggeneandvaccinedelivery AT thithaolinhnguyen recentadvancesinintranasalliposomesfordruggeneandvaccinedelivery AT hanjoomaeng recentadvancesinintranasalliposomesfordruggeneandvaccinedelivery |